← Back to Patent Explorer
US5280109A Expired / Lapsed US ⏱️ 0.0 years remaining

Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2

Assignee: Ludwig Cancer Research
•
Filing: 1992-01-27
•
Granted: 1994-01-18
•
Expires: 2012-01-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to large latent complexes of TGF- beta 2 and TGF- beta 3, and methods for isolating these. The complex consists of a dimerized form of TGF- beta 2 or TGF- beta 3, the appropriate latency associated peptide, and the latent TGF- beta 1 binding protein, referred to as LTBP. Also described is a protein which binds to all of TGF- beta 1, TGF- beta 2 and TGF- beta 3, but is immunologically distinct from LTBP, referred to as LTBP-2.

Inventors

  • 👤 Kohei Miyazono
  • 👤 Carl-Henrik Heldin
  • 👤 Anders Olofsson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:58
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/495

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 45 words
Isolated large latent TGF-β complex consisting of: (i) latent, TGF-β1 binding protein; (ii) dimerized, beta latency associated peptide linked to said latent TGF-β1 binding protein via a disulphide bond, and (iii) dimerized TGF-β2 or dimerized TGF-β3 non-covalently associated with said dimerized beta latency associated peptide.
Claim 2
Dependent Claim 45 words
Isolated large latent TGF-β complex consisting of: (i) latent, TGF-β1 binding protein; (ii) dimerized, beta latency associated peptide linked to said latent TGF-β1 binding protein via a disulphide bond, and (iii) dimerized TGF-β2 or dimerized TGF-β3 non-covalently associated with said dimerized beta latency associated peptide.
Claim 3
Dependent Claim 15 words
The isolated large latent TGF-β complex of claim 1, wherein said complex contains dimerized TGF-β2.
Claim 4
Dependent Claim 15 words
The isolated large latent TGF-β complex of claim 1, wherein said complex contains dimerized TGF-β3.

References Cited (Backward Citations)

WO1991013152A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-01-17 1997-07-19 1998-01-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-01-17 2001-07-19 2002-01-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-01-17 2005-07-19 2006-01-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag